Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized Bismuth Quadruple Therapy vs Standard Triple Therapy for H. pylori
NCT05664685Phase 4Completed
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Oct 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bismuth subsalicylate in Helicobacter pylori infection, sponsored by Pontificia Universidad Católica de Chile. Started Oct 2022; status: completed.
02
Drugs
bismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05664685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05664685.